nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—ABCC2—Sulfasalazine—ankylosing spondylitis	0.176	0.188	CbGbCtD
Oxaliplatin—CYP1B1—Dexamethasone—ankylosing spondylitis	0.167	0.179	CbGbCtD
Oxaliplatin—ABCG2—Sulfasalazine—ankylosing spondylitis	0.159	0.17	CbGbCtD
Oxaliplatin—ABCC2—Dexamethasone—ankylosing spondylitis	0.0879	0.0941	CbGbCtD
Oxaliplatin—ABCG2—Dexamethasone—ankylosing spondylitis	0.0795	0.085	CbGbCtD
Oxaliplatin—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0733	0.0785	CbGbCtD
Oxaliplatin—ABCC2—Methotrexate—ankylosing spondylitis	0.0706	0.0756	CbGbCtD
Oxaliplatin—ABCG2—Methotrexate—ankylosing spondylitis	0.0639	0.0683	CbGbCtD
Oxaliplatin—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0567	0.0606	CbGbCtD
Oxaliplatin—MPO—IL23-mediated signaling events—IL23R—ankylosing spondylitis	0.00581	0.0884	CbGpPWpGaD
Oxaliplatin—ATP7B—Ion channel transport—ANO6—ankylosing spondylitis	0.00526	0.0801	CbGpPWpGaD
Oxaliplatin—ATP7A—Ion channel transport—ANO6—ankylosing spondylitis	0.00447	0.0681	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon gamma signaling—HLA-C—ankylosing spondylitis	0.00275	0.0418	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL17A—ankylosing spondylitis	0.00231	0.0352	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL12B—ankylosing spondylitis	0.00215	0.0327	CbGpPWpGaD
Oxaliplatin—ATP7B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00183	0.0279	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00176	0.0268	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—IL10—ankylosing spondylitis	0.00169	0.0257	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.00165	0.0251	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon gamma signaling—HLA-B—ankylosing spondylitis	0.00162	0.0247	CbGpPWpGaD
Oxaliplatin—ATP7A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00156	0.0237	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon gamma signaling—HLA-A—ankylosing spondylitis	0.00151	0.0229	CbGpPWpGaD
Oxaliplatin—SLC31A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00149	0.0227	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	0.00149	0.0227	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—HLA-C—ankylosing spondylitis	0.00134	0.0204	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.00117	0.0178	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.00102	0.0156	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—CRP—ankylosing spondylitis	0.000953	0.0145	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.000896	0.0136	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—KIR3DL1—ankylosing spondylitis	0.000887	0.0135	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000845	0.0129	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—CRP—ankylosing spondylitis	0.000831	0.0127	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—HLA-B—ankylosing spondylitis	0.000793	0.0121	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000778	0.0119	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000757	0.0115	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—HLA-A—ankylosing spondylitis	0.000735	0.0112	CbGpPWpGaD
Oxaliplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TNF—ankylosing spondylitis	0.000671	0.0102	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.00066	0.0101	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000625	0.00951	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—TNF—ankylosing spondylitis	0.000598	0.00911	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.00056	0.00853	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00055	0.00837	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IL1R2—ankylosing spondylitis	0.000537	0.00818	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00053	0.00807	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.00053	0.00807	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00052	0.00793	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—ERAP1—ankylosing spondylitis	0.000509	0.00776	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000491	0.00748	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.00049	0.00746	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.00049	0.00746	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CARD9—ankylosing spondylitis	0.000466	0.0071	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.000463	0.00704	CbGpPWpGaD
Oxaliplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—ankylosing spondylitis	0.000437	0.00666	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TNF—ankylosing spondylitis	0.000431	0.00657	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000401	0.0061	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TNF—ankylosing spondylitis	0.000376	0.00573	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000376	0.00573	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000348	0.00531	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000345	0.00525	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000343	0.00522	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000332	0.00505	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000328	0.005	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000321	0.0049	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—B3GNT2—ankylosing spondylitis	0.000312	0.00476	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000299	0.00455	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-C—ankylosing spondylitis	0.000293	0.00446	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IL1RN—ankylosing spondylitis	0.000254	0.00387	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000235	0.00358	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000235	0.00358	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD79A—ankylosing spondylitis	0.000223	0.0034	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—B3GNT2—ankylosing spondylitis	0.000201	0.00307	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—IL1A—ankylosing spondylitis	0.000183	0.00279	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD40LG—ankylosing spondylitis	0.000182	0.00277	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—B3GNT2—ankylosing spondylitis	0.000179	0.00272	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-B—ankylosing spondylitis	0.000173	0.00264	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—B3GNT2—ankylosing spondylitis	0.000171	0.00261	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—B3GNT2—ankylosing spondylitis	0.000167	0.00254	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-A—ankylosing spondylitis	0.00016	0.00244	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CRP—ankylosing spondylitis	0.000153	0.00233	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—TLR4—ankylosing spondylitis	0.000147	0.00223	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000145	0.00221	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000145	0.00221	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—B3GNT2—ankylosing spondylitis	0.000115	0.00175	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	9.24e-05	0.00141	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	9.24e-05	0.00141	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—B3GNT2—ankylosing spondylitis	8.01e-05	0.00122	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—B3GNT2—ankylosing spondylitis	7.29e-05	0.00111	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—B3GNT2—ankylosing spondylitis	7.22e-05	0.0011	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—B3GNT2—ankylosing spondylitis	6.73e-05	0.00102	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	5.23e-05	0.000797	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—B3GNT2—ankylosing spondylitis	4.94e-05	0.000752	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	3.15e-05	0.000479	CbGpPWpGaD
